methylethyl(silatrane-1-ylmethyl)sulfonium has been researched along with Arteriosclerosis in 2 studies
*Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaplan, BS; Kuznetsov, IG; Rasulov, MM; Velikaia, MV; Voronkov, MG | 1 |
| Kuznetsov, IG; Rasulov, MM; Sorokin, MS; Voronkov, MG | 1 |
2 other study(ies) available for methylethyl(silatrane-1-ylmethyl)sulfonium and Arteriosclerosis
| Article | Year |
|---|---|
[The anticoagulant and antisclerotic effects of isopropoxygermatrane and methylethyl(silatrane-1-ylmethyl)sulfonium iodide].
Topics: Animals; Anticoagulants; Arteriosclerosis; Blood Coagulation; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Nitriles; Onium Compounds; Organometallic Compounds; Rabbits; Silicon; Sulfonium Compounds; Time Factors | 1989 |
[Methylethyl(silatran-1-ylmethyl)sulfonium iodide--an inhibitor of the development of experimental atherosclerosis of the aorta].
Topics: Animals; Aortic Diseases; Arteriosclerosis; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Citrates; Citric Acid; Drug Synergism; Hydrolysis; Lipids; Rabbits; Salicylates; Silicon; Sulfonium Compounds | 1989 |